Page last updated: 2024-08-23

dermatan sulfate and Deficiency, Factor 5

dermatan sulfate has been researched along with Deficiency, Factor 5 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lindhoff-Last, E; Schindewolf, M1
Baker, RI; Gilmore, G; Thom, J1

Other Studies

2 other study(ies) available for dermatan sulfate and Deficiency, Factor 5

ArticleYear
Alternative anticoagulation with danaparoid in two pregnancies in a patient with former heparin-induced thrombocytopenia (HIT), homozygous factor V Leiden mutation, a history of venous thrombosis and recurrent pregnancy losses.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:4

    Topics: Abortion, Habitual; Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Factor V; Factor V Deficiency; Female; Heparin; Heparitin Sulfate; Homozygote; Humans; Infant, Newborn; Male; Platelet Count; Point Mutation; Pregnancy; Pregnancy Complications, Hematologic; Thrombocytopenia; Translocation, Genetic; Venous Thrombosis

2008
Diagnosis of APC resistance in patients on standard or low molecular weight heparin.
    Thrombosis and haemostasis, 1996, Volume: 75, Issue:2

    Topics: Anticoagulants; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Disease Susceptibility; Factor V Deficiency; False Negative Reactions; Heparin; Heparin Lyase; Heparitin Sulfate; Heterozygote; Humans; Partial Thromboplastin Time; Polysaccharide-Lyases; Protein C; Reagent Kits, Diagnostic; Sensitivity and Specificity; Thromboembolism

1996